Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 23.25% | 39.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 23.25% | 39.06% | |||
| Cost of Revenue | 16.37% | 41.74% | |||
| Gross Profit | 24.55% | 38.57% | |||
| SG&A Expenses | 2.25% | 0.08% | |||
| Depreciation & Amortization | 142.67% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.08% | 4.06% | |||
| Operating Income | 19.23% | 49.42% | |||
| Income Before Tax | -758.64% | 92.98% | |||
| Income Tax Expenses | 42.64% | 27.58% | |||
| Earnings from Continuing Operations | -657.58% | 91.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -657.58% | 91.90% | |||
| EBIT | 19.23% | 49.42% | |||
| EBITDA | 23.42% | 50.67% | |||
| EPS Basic | -652.87% | 91.98% | |||
| Normalized Basic EPS | 19.46% | 47.30% | |||
| EPS Diluted | -655.34% | 91.99% | |||
| Normalized Diluted EPS | 19.46% | 47.30% | |||
| Average Basic Shares Outstanding | 0.66% | 0.87% | |||
| Average Diluted Shares Outstanding | 0.66% | 0.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||